Stratrix
Start here

Most valuations are not the kind people picture

Ask someone how a company is valued and they will describe a discounted cash flow: forecast the cash, discount it back, add it up. That is the method in the textbooks and the one that sounds most like analysis. It is not the one most valuations use. Aswath Damodaran, who teaches valuation at New York University's Stern School of Business, notes that "almost 90% of equity research valuations and 50% of acquisition valuations use some combination of multiples and comparable companies" 1. In his words, "most valuations are relative valuations" 1.

That is not a scandal. It is a clue. A discounted cash flow and a multiple are not two ways of getting the same number; they answer different questions. One asks what the business is worth to whoever owns it, given what it will earn. The other asks what the market, or a buyer, is paying for things like it today. Both can be right at the same time and far apart, and the gap between them is often the most interesting number in the room.

Choosing a valuation method is choosing a question. Ask the wrong one and the arithmetic will not save you.

Decision guide

Which valuation method fits your question?

Answer up to three questions about what the valuation is for. The picker names the method that answers that question, what to pair it with, and where it misleads. The mapping is Stratrix's judgment, built on the four approaches in Damodaran's survey.

What do you need the valuation for?
Start here

The four families, and the question each answers

Damodaran groups the methods into four approaches 1. The picker above adds the forms each takes in practice.

ApproachThe question it answersCommon formsWatch out for
Discounted cash flowWhat is it worth to its owners, given the cash it will produce?DCF of free cash flow; economic profitA terminal value that carries most of the answer; a discount rate nobody agreed
Relative valuationWhat are buyers or investors paying for similar things today?Trading comparables; precedent transactionsComparables that are not comparable; a market that is wrong as a whole
Liquidation and accountingWhat are the parts worth, separately or sold off?Sum of the parts; liquidation value; book valueParts valued at prices nobody would pay all at once
Contingent claimWhat is a right to decide later worth?Real options; option pricingPrecision the inputs cannot support

Damodaran's own descriptions are worth having in full: discounted cash flow "relates the value of an asset to the present value of expected future cashflows"; relative valuation "estimates the value of an asset by looking at the pricing of 'comparable' assets relative to a common variable like earnings, cashflows, book value or sales"; and contingent claim valuation "uses option pricing models to measure the value of assets that share option characteristics" 1.

In practice

Use two methods, and explain the gap

A single valuation number invites a single question: is it right? Two numbers from two methods invite a better one: why do they differ? When a discounted cash flow says $40 a share and the trading comparables say $55, either the market expects more growth than your forecast, or the comparables are richer businesses, or the market is wrong. Each answer leads somewhere useful. A single number leads nowhere.

  • For an acquisition: precedent transactions for what buyers have paid, and a discounted cash flow with and without the synergies for what the business is worth to you. The gap between the two is what you would be paying for your own plans; see M&A synergies.
  • For an investment decision inside a company: a discounted cash flow, ranked by net present value; see NPV vs. IRR. Multiples rarely exist for a single project.
  • For a market check: trading comparables, with a discounted cash flow to say whether the market's price implies growth you believe.
  • For a breakup or a spin-off: the sum of the parts, each part valued by the method that suits it, against the value of the whole; our base rates for spin-offs show how those decisions have ended.
In practice

The traps that cut across every method

  • Mixing enterprise and equity values. An EV multiple applied to net income, or a P/E applied to EBITDA, gives a confident wrong answer; see enterprise value vs. equity value.
  • Precedents as proof. What buyers paid includes control, synergy and sometimes overpayment; see precedent transactions.
  • One assumption carrying the answer. In most models, one or two inputs decide the result. Find them before you defend the number; see sensitivity analysis.
  • A valuation built backward from a price. If the conclusion was chosen first, every method will agree with it. Write the question, and the method, before anyone mentions a number.

Questions

What are the main valuation methods?
Discounted cash flow, which values future cash; relative valuation, which uses the multiples of comparable companies or past acquisitions; liquidation and accounting valuation, which values the existing assets or what they would fetch; and contingent claim valuation, which treats some assets as options.
Which valuation method is most used?
Multiples. Aswath Damodaran notes that almost 90 percent of equity research valuations and half of acquisition valuations use some combination of multiples and comparable companies.
What is the difference between DCF and comparables?
A discounted cash flow estimates what a business is worth to its owners from the cash it will produce. Comparables estimate what investors or buyers are paying for similar businesses today. They answer different questions, and the gap between them is often informative.
Which valuation method should I use for an acquisition?
Precedent transactions for what buyers have paid for similar companies, and a discounted cash flow with and without the synergies you expect, to see what the target is worth to you. If a financial buyer may bid, a leveraged buyout analysis shows what it can afford.
How do you value a young company with little history?
A single forecast is rarely credible. Value two or three scenarios with their own cash flows, or treat future investment decisions as options, and keep the precision modest.

Sources

  1. Damodaran, A. (2006). Valuation Approaches and Metrics: A Survey of the Theory and Evidence. Stern School of Business, New York University.

For information and strategic analysis only, not investment advice. Stratrix does not recommend buying, selling or holding any security.

Tools to try

More from Stratrix

Strategy Packs
The Road Not Taken

“What did the decision you did not take actually cost?”

One decision per pack: the framework, a working model, the sourced cases and the board material.

See the pack — $499 →

Stratrix Team

Every Casebook, three Strategy Packs a seat each year and Ask Stratrix, for teams that face these decisions all year.

$1,999 a year · $499 a seatWhat is included →

Weekly email

Stratonomics, every Tuesday

One data story every Tuesday: what happened, what it means, and the figures you can quote. Free.

We'll email you a link to confirm. Unsubscribe anytime. Privacy policy.